A. Kalatanova, V. Nebogatikov, A. Nedorubov, A. Dorotenko
{"title":"以含有牛大脑皮质多肽的药物为例,对儿科药物安全性研究的优化方法的经验","authors":"A. Kalatanova, V. Nebogatikov, A. Nedorubov, A. Dorotenko","doi":"10.29296/2618723x-2021-02-10","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":131225,"journal":{"name":"Laboratornye Zhivotnye dlya nauchnych issledovanii (Laboratory Animals for Science)","volume":"14 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Experience with an optimized methodology of safety studies for pediatric medicines using the example of a drug containing cattle cerebral cortex polypeptides\",\"authors\":\"A. Kalatanova, V. Nebogatikov, A. Nedorubov, A. Dorotenko\",\"doi\":\"10.29296/2618723x-2021-02-10\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":131225,\"journal\":{\"name\":\"Laboratornye Zhivotnye dlya nauchnych issledovanii (Laboratory Animals for Science)\",\"volume\":\"14 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Laboratornye Zhivotnye dlya nauchnych issledovanii (Laboratory Animals for Science)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29296/2618723x-2021-02-10\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laboratornye Zhivotnye dlya nauchnych issledovanii (Laboratory Animals for Science)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29296/2618723x-2021-02-10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Experience with an optimized methodology of safety studies for pediatric medicines using the example of a drug containing cattle cerebral cortex polypeptides